Rights and permissions
About this article
Cite this article
Rituximab improves response in relapsed/refractory DLBCL. Inpharma Wkly. 1448, 13 (2004). https://doi.org/10.2165/00128413-200414480-00037
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414480-00037